Mumbai, India, June 2026 – Cipla has announced the promotion of Yashu Arora to Group Business Head – Respiratory Orals Vertical, recognizing his significant contributions to the organization and his successful leadership across multiple business functions over the years.
In his expanded role, Arora will lead one of Cipla’s key respiratory businesses, driving strategic growth, market leadership, commercial excellence, and innovation across the Respiratory Orals portfolio. His promotion reflects Cipla’s continued focus on strengthening leadership capabilities to support its long-term growth ambitions in respiratory care and specialty pharmaceuticals.
Yashu Arora has been associated with Cipla for more than a decade, building a distinguished career across sales leadership, business management, and commercial strategy.
Most recently, he served as Business Unit Head, where he was responsible for business growth, portfolio management, market expansion, and operational excellence. During his tenure, he played a key role in strengthening the performance of the business unit through strategic execution, customer-centric initiatives, and team leadership.
Prior to this, Arora served as Director (Sales Head), leading large-scale sales operations and driving commercial effectiveness across key therapeutic segments. His leadership contributed significantly to market expansion, revenue growth, team capability development, and execution excellence across the organization.
Over the course of his 11-year journey with Cipla, he has built extensive expertise in sales leadership, business integration, commercial strategy, business unit management, stakeholder engagement, and market development, making him well-positioned to lead the Respiratory Orals Vertical during its next phase of growth.
About Cipla
Cipla is one of the world’s leading pharmaceutical companies and has been serving patients and healthcare professionals since 1935. Guided by its purpose of “Caring for Life,” the company has consistently focused on making high-quality healthcare more accessible and affordable across the globe.
Today, Cipla operates in more than 80 countries and offers over 1,500 products across multiple therapeutic categories and dosage forms. The company is widely recognized for its pioneering role in improving access to HIV/AIDS treatment through its groundbreaking affordable antiretroviral therapy initiative launched in Africa in 2001.
Cipla has also established itself as a leader in respiratory care, with one of the industry’s most comprehensive respiratory portfolios spanning awareness, prevention, diagnosis, treatment, and adherence solutions. Leveraging its deep expertise in respiratory medicine, the company continues to pursue its vision of becoming a global lung health leader and helping millions of patients breathe better.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
